Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges

Several immune checkpoint blockades (ICBs) capable of overcoming the immunosuppressive roles of the tumor immune microenvironment have been approved by the US Food and Drug Administration as front-line treatments of various tumor types. However, due to the considerable heterogeneity of solid tumor c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncogenesis
Autori principali: Zhu, Lingling, Yu, Xianzhe, Wang, Li, Liu, Jiewei, Qu, Zihan, Zhang, Honge, Li, Lu, Chen, Jiang, Zhou, Qinghua
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2021
Soggetti:
Review Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8272720/
https://ncbi.nlm.nih.gov/pubmed/34247198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41389-021-00335-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi